Zio ECG Utilization Software (ZEUS) System vs Zio AT ECG Monitoring System
AI Verdict
Choose Zio ECG Utilization Software (ZEUS) System if…
Choose Zio ECG Utilization Software (ZEUS) System if your primary need is a powerful, AI-driven cloud platform to process and analyze continuous ECG data from various Zio wearable monitors for comprehensive, retrospective diagnostic insights. This system excels at generating detailed end-of-wear reports to aid in the long-term diagnosis and management of cardiac arrhythmias, integrating seamlessly with your existing EHR for streamlined physician review.
View Zio ECG Utilization Software (ZEUS) System →Choose Zio AT ECG Monitoring System if…
Choose Zio AT ECG Monitoring System if you require mobile cardiac telemetry (MCT) capabilities with real-time or near real-time data transmission for patients needing immediate clinical attention or continuous oversight. This system is ideal for detecting critical, transient arrhythmias where prompt intervention may be necessary, offering a robust service that combines a wearable patch with a wireless gateway for ongoing, active monitoring.
View Zio AT ECG Monitoring System →For physicians evaluating cardiac AI tools from iRhythm Technologies, the Zio ECG Utilization Software (ZEUS) System and the Zio AT ECG Monitoring System offer distinct advantages. The ZEUS System is a cloud-based platform primarily focused on analyzing continuous ECG data from various Zio monitors, including the Zio monitor and Zio Watch. It excels at providing comprehensive end-of-wear reports and integrating with EHR systems, making it ideal for practices that prioritize a robust analytics platform for retrospective review of long-term ECG data.
In contrast, the Zio AT ECG Monitoring System is a wearable mobile cardiac telemetry (MCT) service. Its key practical difference lies in its real-time data transmission capabilities via a wireless gateway, allowing for continuous, uninterrupted ECG recording and the detection of both symptomatic and asymptomatic cardiac events as they occur. Physicians who require immediate or near real-time insights into patient arrhythmias, particularly for those with acute or high-risk conditions, would find the Zio AT system more suitable. Both systems leverage FDA-cleared AI algorithms for arrhythmia detection and offer clinician portals for review, but the Zio AT’s emphasis on real-time monitoring caters to a more immediate diagnostic need.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio ECG Utilization Software (ZEUS) System | Zio AT ECG Monitoring System |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based (AWS EC2 platform) | Cloud-based (data analytics and clinician portal) |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio AT ECG Monitoring SystemTool B (Zio AT) offers a broader usability scope by including a 'MyZiou00ae patient mobile app for symptom logging and education' in addition to the clinician portal and app. While Tool A (ZEUS) provides a web portal and mobile application for healthcare professionals, the patient-facing app in Tool B enhances the overall user experience for the entire care continuum, promoting patient engagement and data collection.
Clinical Value
Zio AT ECG Monitoring SystemTool B (Zio AT) provides a more comprehensive clinical solution as a Mobile Cardiac Telemetry (MCT) service, featuring a wireless gateway for real-time data transmission and explicit detection of both symptomatic and asymptomatic cardiac events. While Tool A (ZEUS) is the underlying AI software for arrhythmia detection, Tool B represents the complete monitoring system that leverages this AI for immediate and continuous clinical insights.
Pricing & Value
TieBoth Tool A and Tool B require direct contact for pricing, and neither provides publicly disclosed pricing details. Without specific cost information or comparative outcome studies tied to cost-effectiveness, it is not possible to determine which tool offers better value. Both are from the same company and likely follow similar non-transparent pricing models.
Enterprise Readiness
Zio ECG Utilization Software (ZEUS) SystemBoth tools are cloud-based, HIPAA compliant, and FDA cleared, indicating a strong foundation for enterprise use. However, Tool A (ZEUS) explicitly lists 'HL7-based EHR integration' as a key feature, which is crucial for seamless interoperability within healthcare systems. While Tool B likely integrates similarly as part of the Zio ecosystem, Tool A's explicit mention gives it an edge in documented enterprise readiness.
Innovation
Zio AT ECG Monitoring SystemBoth tools utilize advanced AI and deep-learned algorithms for ECG analysis. However, Tool B (Zio AT) stands out with its 'wireless gateway for real-time data transmission' as part of its Mobile Cardiac Telemetry service. This real-time capability for continuous monitoring represents a more immediate and proactive approach to cardiac event detection, offering a higher degree of innovation in active patient management.
Support & Docs
TieiRhythm Technologies provides extensive support and documentation for its entire Zio ecosystem, which encompasses both ZEUS (Tool A) and Zio AT (Tool B). This includes 24/7 customer support for both patients and providers, as well as comprehensive 'Instructions for Use' and 'Clinical Reference Manuals' for all Zio devices and software.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio ECG Utilization Software (ZEUS) System | Zio AT ECG Monitoring System |
|---|---|---|
| Name | Zio ECG Utilization Software (ZEUS) System | Zio AT ECG Monitoring System |
| Company | iRhythm Technologies | iRhythm Technologies, Inc. |
| Core Function | AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias. | FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting. |
| Monitoring Duration | Continuous ECG data analysis (up to 14 days) | Continuous, uninterrupted ECG recording for up to 14 days |
| AI Algorithm | AI algorithm for arrhythmia detection and classification; Proprietary deep-learned algorithms for enhanced diagnostic accuracy | FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection |
| Clinician Portal/App | ZioSuite web portal and mobile application for healthcare professionals | ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation |
Videos
Demos, reviews, and walkthroughs featuring Zio ECG Utilization Software (ZEUS) System and Zio AT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio ECG Utilization Software (ZEUS) System or Zio AT ECG Monitoring System
Backers
Who funded each tool's parent company.